Skip to main content
●+254 119 023975 support@dnalabskenya.com
Patient Portal LoginB2B / Doctor Portal
DNA LabsKenya
Medical information Clinical review pending

Diagnostic Testing

Immunohistochemistry Germ Cell Tumour Panel Test

A specialized test using immunohistochemistry to detect markers associated with germ cell tumors, aiding in cancer diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tumor tissue sample, preferably in 10% Formal-saline or Formalin fixed paraffin embedded block.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Ensure the laboratory receives the tumor tissue sample along with a copy of the Histopathology report, the site of biopsy, and relevant clinical history.
Test priceKSh 11,700

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Germ Cell Tumour Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us
01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspicion of a germ cell tumor based on clinical presentation or imaging.
  • ✓Diagnosis of an undifferentiated tumor.
  • ✓Classification of a known germ cell tumor.
  • ✓Assisting in treatment planning for germ cell tumors.
  • ✓Monitoring response to therapy in some cases.
  • ✓Evaluating risk factors or family history related to germ cell tumors.
02

In plain language

What this test helps you understand

This test aids in the diagnosis, classification, and treatment planning of germ cell tumors by identifying specific protein markers within tumor tissue.
The Immunohistochemistry Germ Cell Tumour Panel Test is a diagnostic tool used in oncology to identify specific markers related to germ cell tumors. This test helps doctors diagnose cancer, determine appropriate treatment strategies, and monitor the disease. It analyzes proteins within tumor tissue samples. The key components measured include CD30, CD117, Glypican3, HCG, Inhibin, PLAP, and SALL4. This test is valuable for patients presenting with symptoms suggestive of tumors or those with risk factors like a family history of cancer. Accurate diagnosis and treatment planning are key benefits of this test. Results are typically available within 5 to 7 days. Discuss your results with your healthcare provider for a full understanding.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the laboratory receives the tumor tissue sample along with a copy of the Histopathology report, the site of biopsy, and relevant clinical history.
SampleTumor tissue sample, preferably in 10% Formal-saline or Formalin fixed paraffin embedded block.
MethodologyImmunohistochemistry (IHC) using specific antibodies to detect the presence and distribution of target proteins (CD30, CD117, Glypican3, HCG, Inhibin, PLAP, SALL4) in tissue sections.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The test results must be interpreted in the context of the patient's clinical history, imaging findings, and other laboratory results. False negatives or positives can occur. The interpretation requires expertise in pathology.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Germ cell tumors are a type of cancer that develops from the cells that produce eggs (in females) or sperm (in males). They can occur in various parts of the body.
This test helps doctors identify specific markers in a tumor sample to confirm if it is a germ cell tumor, determine its type, and plan the best treatment.
A tissue sample from the tumor is required. This is usually obtained through a biopsy or surgery and should be preserved in formalin or as a paraffin block.
Results are typically available within 5 to 7 days, but this can vary depending on the complexity of the sample. Confirm with the laboratory before booking.
A pathologist, a medical doctor specializing in diagnosing diseases by examining tissues and cells, interprets the results.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Congenital Hypothyroidism Confirmatory Panel Serum Test

Confirms congenital hypothyroidism in newborns by measuring TSH and Free T4 levels. Early detection is crucial for preventing developmental delays. Available across Kenya.

Learn more →

Immunohistochemistry Single Marker With Interpretation Test

A specialized test using immunohistochemistry to detect specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.

Learn more →

Albumin Fluid Test

The Albumin Fluid Test measures albumin levels in body fluids to help diagnose infections and assess conditions affecting fluid balance. Available across Kenya.

Learn more →

Aluminium Plasma Test

Measures aluminium levels in the blood to assess potential exposure, particularly relevant for individuals in industrial settings. Confirm with the laboratory before booking.

Learn more →
Chat on WhatsApp